ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Henri Warembourg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grandmougin, D.
Right arrow Articles by Warembourg, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grandmougin, D.
Right arrow Articles by Warembourg, H.
Related Collections
Right arrow Transplantation - heart

Ann Thorac Surg 2001;71:1438-1441
© 2001 The Society of Thoracic Surgeons


Original article: cardiovascular

Total orthotopic heart transplantation for primary cardiac rhabdomyosarcoma: factors influencing long-term survival

Daniel Grandmougin, MDa, Georges Fayad, MDa, Christophe Decoene, MDa, Annie Pol, MDa, Henri Warembourg, MDa

a Department of Cardiovascular Surgery, Anesthesiology, Cardiologique Hospital, Lille; and Department of Pathology, Calmette Hospital, University of Lille, Lille, France

Accepted for publication January 5, 2001.

Address reprint requests to Dr Grandmougin, Service de Chirurgie Cardiovasculaire, 5ème étage, Hôpital Cardiologique, Bd Pr Leclercq, 59 037 Lille-cedex, France
e-mail: d-grandmougin{at}chru-lille.fr

Background. Primary cardiac sarcomas are uncommon and rare, with an unequal distribution in the population. A dismal prognosis is usually admitted that is related to a high propensity to develop distant metastasis with survival rarely exceeding 2 years. We report a case of a patient with a primary cardiac rhabdomyosarcoma characterized by an exceptional long-term survival after surgical treatment by a total orthotopic heart transplantation. From this limited experience, we reviewed factors that may influence survival to optimize therapeutic strategy.

Methods. A 33-year-old man was found to have a 10-cm primary cardiac rhabdomyosarcoma located in the right atrium and extending to the atrioventricular groove; therefore, resection was not possible. Since no metastases were detected, the patient was scheduled for urgent cardiac transplantation, which was performed after adjuvant radiotherapy.

Results. Postoperative outcome was uneventful and the patient is still alive, with regular follow-up, at 102 months.

Conclusions. In a case of primary rhabdomyosarcoma, heart transplantation, despite immunosuppressive therapy, can provide long-term survival and can be considered for selected patients after rigorous analysis of predictors of survival.




This article has been cited by other articles:


Home page
ESC Textbook of Cardiovascular MedicineHome page
G. Thiene, M. Valente, M. Lombardi, and C. Basso
CHAPTER 20 Tumours of the Heart
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. Malyshev, A. Safuanov, I. Gladyshev, V. Trushyna, L. Abramovskaya, and A. Malyshev
Primary Left Atrial Leiomyosarcoma: Literature Review and Lessons of a Case
Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 435 - 440.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.